Trial
NCT04239040
GVAX Plus Checkpoint Blockade in Neuroblastoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
—
Condition
Neuroblastoma
Intervention
Tissue collection
Why stopped
Manufacturing issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-19